FIGURE 6.
Targeted locust amplification 13 standard curve performances (panel A and B) and minimal residual disease trends in bone marrow (blue line) and peripheral blood (green line) follow ups targeting BCL1‐TLA (panel C)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.